Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.870
+0.060 (3.31%)
At close: Oct 17, 2025, 4:00 PM EDT
1.890
+0.020 (1.06%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Gain Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
67.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 55.18K | -77.46K | -58.40% |
| Dec 31, 2022 | 132.64K | -1.29K | -0.96% |
| Dec 31, 2021 | 133.93K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GANX News
- 2 days ago - Gain Therapeutics to Attend the 2025 Maxim Growth Summit - GlobeNewsWire
- 9 days ago - Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease - GlobeNewsWire
- 12 days ago - Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson's Patients at International Congress of Parkinson's Disease and Movement Disorders® - GlobeNewsWire
- 25 days ago - Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025 - GlobeNewsWire
- 4 weeks ago - Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson's Disease - GlobeNewsWire
- 6 weeks ago - Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation - GlobeNewsWire
- 2 months ago - Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference - GlobeNewsWire